Researchers identify potential for prenatal gene therapy

December 10, 2001

Minneapolis / St. Paul (December 10, 2001)--University of Minnesota (U of M) Cancer Center researchers will present findings that demonstrate promise for prenatal gene therapy to correct neurological and genetic disorders today (Monday, Dec. 10) at the American Society of Hematology Conference in Orlando, Fla.

Angela Panoskaltsis-Mortari, Ph.D., will show that the "Sleeping Beauty" transposon may be useful for in utero delivery of gene sequences capable of correcting congenital disorders of the blood and immune system that are challenging to treat post-natally.

"Sleeping Beauty" is an enzyme named by the U of M Cancer Center researchers who discovered its potential to link specific genes with specific functions (see Cell, November 1997). Mortari will demonstrate that when immune deficient mice fetuses were injected with the Sleeping Beauty enzyme, easily detectable green fluorescent protein (GFP) was seen in the liver, lung, heart, kidney, skin, and brain. Important for the correction of lymphohematopoietic genetic disorders, GFP expression was present in both the spleen and bone marrow, indicating that Sleeping Beauty can localize to hematopoietic organs in vivo.

Details of Mortari's presenation:

Time: Monday, December 10, 2001,
10:30 a.m. EST
Session name: Vector Development and Assessment
Title: In Utero Delivery of Sleeping Beauty Transposon Results in Long- Term Multi-Organ Expression: Potential for Prenatal Gene Therapy of Genetic Disorders.

Jakub Tolar, M.D., Ph.D., will show for the first time in mice that multipotent adult progenitor cells (MAPCs), or bone marrow stem cells, engraft and differentiate into brain and liver cells after in utero transfer. Their results support the possibility of future clinical use of adult bone marrow stem cells in attempts to correct neurological, hepatic, muscular and possibly other types of congenital disorders pre-natally.

Details of Tolar's presentation:

Time: Monday, December 10,
2001, 8:15 a.m. EST
Session name: Experimental Transplantation
Title: The in utero transfer of murine multipotent adult progenitor cells (MAPCs) results in brain and liver differentiation
-end-
Further details about their presentations can be found on the ASH Web site, www.hematology.org.

The University of Minnesota Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center. Awarded more than $68 million in peer-reviewed grants during fiscal year 2001, the center conducts cancer research that advances knowledge and enhances care. The center also engages community outreach and public education efforts addressing cancer. For more information on cancer in general, visit the Web site at www.cancer.umn.edu or call 1-888-CANCER MN (1-888-226-2376 or 612/624-2620).

Contacts:

Sarah Youngerman, Academic Health Center, (612) 624-2346

Melanie Boulay, University of Minnesota Cancer Center, (612) 626-1107

University of Minnesota

Related Bone Marrow Articles from Brightsurf:

Researchers identify the mechanism behind bone marrow failure in Fanconi anaemia
Researchers at the University of Helsinki and the Dana-Farber Cancer Institute have identified the mechanism behind bone marrow failure developing in children that suffer from Fanconi anaemia.

Nanoparticles can turn off genes in bone marrow cells
Using specialized nanoparticles, MIT engineers have developed a way to turn off specific genes in cells of the bone marrow, which play an important role in producing blood cells.

How stress affects bone marrow
Researchers from Tokyo Medical and Dental University (TMDU) identified the protein CD86 as a novel marker of infection- and inflammation-induced hematopoietic responses.

3D atlas of the bone marrow -- in single cell resolution
Stem cells located in the bone marrow generate and control the production of blood and immune cells.

Dangerous bone marrow, organ transplant complication explained
Scientists have discovered the molecular mechanism behind how the common cytomegalovirus can wreak havoc on bone marrow and organ transplant patients, according to a paper published in the journal Cell & Host Microbe.

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.

Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology.

Cells that make bone marrow also travel to the womb to help pregnancy
Bone marrow-derived cells play a role in changes to the mouse uterus before and during pregnancy, enabling implantation of the embryo and reducing pregnancy loss, according to research published Sept.

Uncovering secrets of bone marrow cells and how they differentiate
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells.

Zebrafish help researchers explore alternatives to bone marrow donation
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation.

Read More: Bone Marrow News and Bone Marrow Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.